Somatic Symptoms Tied to Depression With Ovarian Cancer
via HealthDayMONDAY, May 11, 2026 -- Somatic symptoms may disproportionately inflate depression scores among patients with ovarian cancer, according to a study published online May 11 in Cancer.
Rachel Telles, from the University of Iowa in Iowa City, and colleagues examined the contribution of somatic symptoms to the assessment of depression severity in patients with ovarian cancer. The analysis included 428 patients with ovarian cancer who completed psychosocial assessments at one to two weeks before surgical intervention or initiation of neoadjuvant chemotherapy and at one-year follow-up.
The researchers found that somatic items showed differential functioning between groups. Patients with ovarian cancer were more likely to endorse somatic symptoms at lower levels of depression versus healthy aging adults. Additionally, those with ovarian cancer required a lower level of depression to endorse somatic items versus nonsomatic items. At one year, these differences between patients with cancer and healthy aging adults were no longer present.
"We intend these findings to help guide assessments of depressive symptoms to discriminate between physical symptoms that are related to cancer and cognitive or affective symptoms that may respond to more traditional interventions for depression," Telles said in a statement. "We hope that more tailored care will improve outcomes for these patients."
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-12 02:42
Read more
- Crackdown on Vapes Falling Short, Report Finds
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS
- Positive Affect Treatment Outperforms Negative Affect Treatment in Depression, Anxiety
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- Combining Cannabinoid With Opioid Does Not Relieve Pain in Knee Osteoarthritis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions